76 related articles for article (PubMed ID: 17239341)
21. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
22. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB; Lerner UH
Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
24. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
25. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
Takahashi N
Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
[TBL] [Abstract][Full Text] [Related]
26. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.
Ha J; Choi HS; Lee Y; Lee ZH; Kim HH
Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574
[TBL] [Abstract][Full Text] [Related]
27. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction.
Lundberg P; Koskinen C; Baldock PA; Löthgren H; Stenberg A; Lerner UH; Oldenborg PA
Biochem Biophys Res Commun; 2007 Jan; 352(2):444-8. PubMed ID: 17126807
[TBL] [Abstract][Full Text] [Related]
28. Bone metastasis: can osteoclasts be excluded?
Martin TJ; Mundy GR
Nature; 2007 Feb; 445(7130):E19; discussion E19-20. PubMed ID: 17314931
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
Oikawa A; Kobayashi M; Okamatsu Y; Shinki T; Kamijo R; Yamamoto M; Hasegawa K
J Periodontal Res; 2007 Aug; 42(4):367-76. PubMed ID: 17559635
[TBL] [Abstract][Full Text] [Related]
30. Active caspase-3 is required for osteoclast differentiation.
Szymczyk KH; Freeman TA; Adams CS; Srinivas V; Steinbeck MJ
J Cell Physiol; 2006 Dec; 209(3):836-44. PubMed ID: 16972256
[TBL] [Abstract][Full Text] [Related]
31. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
Tanaka S
Am J Nephrol; 2007; 27(5):466-78. PubMed ID: 17652963
[TBL] [Abstract][Full Text] [Related]
32. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
33. Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANK.
Zhao Y; Jin M; Ma J; Zhang S; Li W; Chen Y; Zhou Y; Tao H; Liu Y; Wang L; Han H; Niu G; Tao H; Liu C; Gao B
FEBS Lett; 2013 Sep; 587(18):2958-64. PubMed ID: 23954298
[TBL] [Abstract][Full Text] [Related]
34. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
37. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans].
Kobayashi Y; Takahashi N
Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890
[TBL] [Abstract][Full Text] [Related]
38. Activated platelets retain their potential to induce osteoclast-like cell formation in murine bone marrow cultures.
Maitz P; Kandler B; Fischer MB; Watzek G; Gruber R
Platelets; 2006 Nov; 17(7):477-83. PubMed ID: 17074724
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and functional characterization of the porcine extracellular domain of Receptor Activator of NF-κB Ligand (sRANKL).
Böcker W; Radic T; Schönitzer V; Haasters F; Mutschler W; Schieker M
Gene; 2012 Jan; 492(1):296-304. PubMed ID: 22062001
[TBL] [Abstract][Full Text] [Related]
40. Porphyrin Derivatives Inhibit the Interaction between Receptor Activator of NF-κB and Its Ligand.
Chypre M; Madel MB; Chaloin O; Blin-Wakkach C; Morice C; Mueller CG
ChemMedChem; 2017 Oct; 12(20):1697-1702. PubMed ID: 28885764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]